⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
BSX
CAH
MDT
GEHC
XRAY
AMGN
AZN
BMY
LLY
MRK
PFE
SNY
TEVA
JNJ
BIIB
GILD
NVS
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMAT
MU
NXPI
ASML
ADI
LRCX
KLAC
CDNS
SNPS
MCHP
ON
STM
MRVL
AEHR
TER
PAYX
CTAS
WST
ZBRA
VRSN
NOW
CRM
ADBE
PANW
CSCO
ACN
HPQ
ORCL
SAP
PTC
ALGN
ESTC
DDOG
SMCI
EXAS
CRSP
EDIT
BEAM
NTLA
REGN
VRTX
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
IQ
BILI
VIPS
HTHT
EDU
TAL
MELI
AMZN
NFLX
DIS
CMCSA
VZ
T
SIRI
GOOGL
AAPL
META
TSLA
GE
PHI
BRKR
AUR
FONR
BFLY
CRI
EXEL
TAK
ABSI
JHG
XNCR
MOD
ARVN
CLAR
BNTX
FOR
ORIC
COOK
OWL
MTA
SKIN
HYPR
ALLT
MAGN
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Grow Significantly at a CAGR of 6.8% During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Pipeline | DelveInsight
prnewswire.com
CLLS
AUTL
FATE
GILD
NVS
Systemic Lupus Erythematosus Market Report Now Available — Segments Biologics, Small Molecules, Drug Classes, Administration Routes, and Therapy Types
globenewswire.com
ABBV
AMGN
AZN
BMY
GSK
NVS
PFE
SNY
BIIB
Nanomedicine Market Report Examines Products, Services and Growth Opportunities Through 2030
globenewswire.com
ABT
ARWR
BMY
GEHC
GILD
INV
JNJ
TMO
MRK
NVS
PFE
TEVA
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Next Generation Drug Conjugates Market Report (2nd Edition) | Trends, Strategies and Sales Forecast 2026-2035
globenewswire.com
NVS
NVO
AZN
Biopharmaceutical Contract Manufacturing Market (7th Edition) Now Available - Maps Manufacturing Capacity and Regulatory Dynamics Across 25+ Countries Over 2026-2035
globenewswire.com
ABBV
CAT
NVS
Global Cancer Immunotherapy Market Report 2026 | Industry to Reach $311.43 Billion by 2031, Driven by Precision Oncology and Cell Therapy Innovation
globenewswire.com
AMGN
AZN
BMY
MRK
PFE
NVS
GSK
LLY
ABBV
JNJ
REGN
SNY
BE
BNTX
MRNA
IOVA
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
PTC
BMRN
SAVA
PFE
CAT
TMO
LH
VERI
INCY
GILD
MRK
REGN
JAZZ
CELU
OMER
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
CSL
BMRN
PFE
LNZA
TMO
MRK
CYN
INCY
GSK
JAZZ
GILD
CELU
OMER